Progestogens in Menopausal Hormone Therapy

    January 2015 in “ Przeglad Menopauzalny ”
    Małgorzata Bińkowska, Jarosław Woroń
    Image of study
    TLDR Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.
    The document from 2015 reviews the role of progestogens in menopausal hormone therapy (MHT), emphasizing their critical role in preventing endometrial hyperplasia and cancer in women with an intact uterus. It discusses the selection of progestogens based on their action mechanisms, side effects, and the need to consider aging-related changes in drug pharmacokinetics. Various progestogens, such as dienogest, drospirenone, dydrogesterone, levonorgestrel, norethisterone, cyproterone acetate, and medroxyprogesterone acetate, are examined for their specific uses in MHT and contraception, and their effects on lipid profiles, coagulation, carbohydrate metabolism, and bleeding patterns. The document also explores the impact of progestogens on breast cancer risk and cardiovascular health, indicating that understanding their differences is crucial for tailoring MHT to individual patient needs.
    Discuss this study in the Community →

    Related Community Posts Join

    3 / 3 results

      community medication for hair loss spironolactone

      in Female  3 upvotes 1 year ago
      41-year-old female experienced slow hair thinning, took finasteride for a year, then switched to spironolactone. Irregular periods occurred, seeking advice on long-term side effects and considering a third medication.

      community 4600 - result 9 month - Dr. Carman

      in Progress Pictures  255 upvotes 9 months ago
      A user shared their 9-month post-hair transplant results with 4600 grafts, using only Nourkin hair vitamins, Vitamin D, and B12, and expressed satisfaction. The replies debated the necessity of medications like finasteride and minoxidil for maintaining hair health.

    Similar Research

    5 / 471 results